Abstract
Definite accurate diagnosis for Creutzfeldt–Jakob disease (CJD) depends on neuropathologic examination of brain biopsy or autopsy. However, transmissible nature makes the invasive examination dangerous. This study was set to determine that the clinical features are for the diagnosis of CJD through a comparison study. We compared clinical features of two cases with initial diagnosis of sporadic CJD. One case was finally diagnosed as definite sporadic CJD. According to World Health Organization diagnosis criteria, the other one, which had been diagnosed as probable sporadic CJD, was confirmed as limbic encephalitis after long-term follow-up. Compared with the case of definite sporadic CJD, the misdiagnosed case did not present typical electroencephalogram (EEG) and diffusion-weighted in magnetic resonance images (DWI) of CJD. However, cerebrospinal fluid in the misdiagnosed patient showed 14-3-3 protein positivity. The patient conditions improved after treatment. Through this case comparison, we conclude that EEG and DWI are necessary for accurate diagnosis of sporadic CJD. Further, long-term follow-up is crucial to diagnosis and treatment of CJD.
Similar content being viewed by others
References
Cousens, S. N., Zeidler, M., Esmonde, T. F., et al. (1997). Sporadic Creutzfeldt–Jakob disease in the United Kingdom: Analysis of epidemiological surveillance data for 1970–96. BMJ, 315, 389–395.
Hansen, H. C., Zschocke, S., Sturenburg, H. J., et al. (1998). Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt–Jakob disease. Acta Neurologica Scandinavica, 97, 99–106.
Hill, A. F., Joiner, S., Wadsworth, J. D., et al. (2003). Molecular classification of sporadic Creutzfeldt–Jakob disease. Brain, 126, 1333–1346.
Peoc’h, K., Delasnerie-Laupretre, N., Beaudry, P., et al. (2006). Diagnostic value of CSF 14-3-3 detection in sporadic CJD diagnosis according to the age of the patient. European Journal of Neurology, 13, 427–428.
Prusiner, S. B. (1993). Genetic and infectious prion diseases. Archives of Neurology, 50, 1129–1153.
Prusiner, S. B. (2001). Shattuck lecture–neurodegenerative diseases and prions. New England Journal of Medicine, 344, 1516–1526.
Roos, R., Gajdusek, D. C., & Gibbs, C. J. (1973). The clinical characteristics of transmissible Creutzfeldt–Jakob disease. Brain, 96, 1–20.
Shiga, Y., Miyazawa, K., Sato, S., et al. (2004). Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease. Neurology, 63, 443–449.
Steinhoff, B. J., Zerr, I., Glatting, M., et al. (2004). Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease. Annals of Neurology, 56, 702–708.
World Health Organisation. (1998). Consensus on criteria for diagnosis of sporadic CJD. Weekly Epidemiol Record, 73, 361–365.
Zerr, I., Pocchiari, M., Collins, S., et al. (2005). Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology, 5, 811–815.
Author information
Authors and Affiliations
Corresponding author
Additional information
Xiongfei Zhao and Yingxin Yu contributed to this manuscript equally as first authors.
Rights and permissions
About this article
Cite this article
Zhao, X., Yu, Y., Zhao, Z. et al. Comparison Between Sporadic and Misdiagnosed Sporadic Creutzfeldt–Jakob Disease: A Report of Two Cases. Cell Biochem Biophys 72, 311–315 (2015). https://doi.org/10.1007/s12013-014-0458-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0458-7